Novartis Operating Income Over Time
NVS Stock | USD 99.66 0.59 0.60% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Novartis Performance and Novartis Correlation. Novartis |
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.215 | Dividend Share 3.919 | Earnings Share 4.4 | Revenue Per Share 23.168 | Quarterly Revenue Growth 0.097 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Novartis AG ADR and related stocks such as Seadrill Limited, Snap Inc, and IF Bancorp Operating Income Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SDRL | 1.8 B | 1.8 B | 1.8 B | 2 B | 1.7 B | 1.5 B | 936 M | 135 M | (360 M) | (317 M) | (408 M) | (108 M) | 72 M | 351.8 M | 487.2 M |
SNAP | (381.7 M) | (381.7 M) | (381.7 M) | (381.7 M) | (381.7 M) | (381.7 M) | (520.4 M) | (3.5 B) | (1.3 B) | (1.1 B) | (862.1 M) | (702.1 M) | (1.4 B) | (1.4 B) | (1.5 B) |
IROQ | 12.4 M | 5.7 M | 8.9 M | 8.5 M | 8.3 M | 8.9 M | 9.8 M | 9.8 M | 13.7 M | 5.9 M | 7.4 M | 10.4 M | 6.3 M | 5.6 M | 7.2 M |
MTCH | 5.7 M | 197.8 M | 323.6 M | 426.2 M | 378.7 M | 179.6 M | (32.6 M) | 188.5 M | 565.1 M | 581.3 M | 745.7 M | 386.6 M | 889.3 M | 2.2 M | 2.1 M |
QCRH | 700 K | 13.6 M | 17.2 M | 19.6 M | 18 M | 20.6 M | 36.6 M | 40.7 M | 52.1 M | 72 M | 73.3 M | 121.5 M | 113.5 M | (8.7 M) | (8.3 M) |
DX | 10.2 M | 63.9 M | 109.2 M | 107.1 M | 53.7 M | 39.1 M | 68.3 M | 70.1 M | 66.6 M | (152.7 M) | 177.5 M | 102.3 M | 186.8 M | (73.1 M) | (69.5 M) |
Novartis AG ADR and related stocks such as Seadrill Limited, Snap Inc, and IF Bancorp Operating Income description
Operating Income is the amount of profit realized from Novartis AG ADR operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Novartis AG ADR is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
Novartis AG ADR | NVS |
HealthcareFama & French Classification | |
Location | Switzerland |
Exchange | New York Stock Exchange |
USD 99.66
Check out Novartis Performance and Novartis Correlation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Novartis Stock analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.